2JOO
The NMR Solution Structure of Recombinant RGD-hirudin
2JOO の概要
| エントリーDOI | 10.2210/pdb2joo/pdb |
| NMR情報 | BMRB: 15405 |
| 分子名称 | Hirudin variant-1 (1 entity in total) |
| 機能のキーワード | mainly beta, blood clotting |
| 由来する生物種 | Hirudo medicinalis (medicinal leech) |
| 細胞内の位置 | Secreted: P01050 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 7042.59 |
| 構造登録者 | |
| 主引用文献 | Song, X.,Mo, W.,Liu, X.,Zhu, L.,Yan, X.,Song, H.,Dai, L. The NMR solution structure of recombinant RGD-hirudin Biochem.Biophys.Res.Commun., 360:103-108, 2007 Cited by PubMed Abstract: The solution structure of a new recombinant RGD-hirudin, which has the activities of anti-thrombin and anti-platelet aggregation, was determined by (1)H nuclear magnetic resonance spectroscopy and compared with the conformations of recombinant wild-type hirudin and hirudin (variant 2, Lys47) of the hirudin thrombin complex. On the basis of total 1284 distance and dihedral angle constraints derived from a series of NMR spectra, 20 conformers were computed with ARIA/CNS programs. The structure of residues 3-30 and 37-48 form a molecular core with two antiparallel beta-sheets as the other two hirudins. However, significant differences were found in the surface electrostatic charge distributions among the three hirudins, especially in the RGD segment of recombinant RGD-hirudin. This difference may be greatly beneficial to its additional function of anti-platelet aggregation. The difference in extended C-terminal makes its both ionic and hydrophobic interactions with the fibrinogen recognition exosite of thrombin more effective. PubMed: 17585879DOI: 10.1016/j.bbrc.2007.06.014 主引用文献が同じPDBエントリー |
| 実験手法 | SOLUTION NMR |
構造検証レポート
検証レポート(詳細版)
をダウンロード






